Parliament Workbench
Data: Official Report to 19 Nov 2026

Official Report · Committee

Continued Petitions

Thyroid and Adrenal Testing and Treatment (PE1463)

Thursday 30 June 2016 Public Petitions Committee About 10:30 Petitions 8 contributions · 4 speakers

Speakers

Choose an MSP to read only their contributions

The record

8 contributions
Johann Lamont Lab The Convener · Glasgow
link

The next continued petition, which is PE1463, by Lorraine Cleaver, is on effective thyroid and adrenal testing, diagnosis and treatment. This is another petition that has been under consideration for several years. The Scottish Government has done some work on the issue, but there are still areas that we could explore, which are outlined in the briefing paper.

I invite members’ views on how the petition should be progressed. Elaine Smith might want to say something first, as someone who has been involved with the petition in the past. That might help our deliberations.

Elaine Smith Lab Central Scotland
link

Certainly. Thank you for inviting me to speak.

The previous Public Petitions Committee did a huge amount of work on the petition and seemed to understand the issues very well. I offer apologies for the fact that Lorraine Cleaver cannot be here this morning; I think that she has come to Parliament on most occasions on which the petition has been considered.

I do not want to go over all the issues again. It is a big women’s issue, in that it predominantly affects women. It is also cross-cutting, in that it is not just a health issue. The fact that someone with the condition might not be able to work means that it gives rise to economic and care issues. It is hugely significant that it affects mainly women.

There is a problem with diagnosis and treatment. Sometimes patients are just parked on T4, which is synthetic thyroxine. Although many members of the medical profession will say that people do well on that, many people who are on it—as I was for many years—do not know that they are not doing well, because they are managing to function. They do not realise that things that they have such as fibromyalgia, difficulty getting up in the morning, thinning hair and dry skin are an indication that they are not doing that well on their T4. For a lot of patients on T3, like me, it makes a huge difference, because they might not convert T4 so well.

Another issue is whether desiccated thyroid hormone should be available. It is available in other countries, and a lot of patients in this country use the internet to get it, but they sometimes have problems with the cloning of cards and suchlike. Buying it from abroad is tempting, but personally I would not want to do that. GPs could prescribe it here, but they are concerned that there might be backlash repercussions. The availability of desiccated thyroid hormone is an important issue.

To cut to the chase, I refer to the choice of actions that the committee has in its paper on the petition. Given that the Public Petitions Committee has done a lot work on the petition—I think that you have about 100 stories, which we got together really quickly, that tell the tale—it would be a shame if the committee closed the petition or even referred it to the Health and Sport Committee. I am not saying that that is not an option, but I think that the petition is a bit more cross-cutting, particularly given the equality issues for women that are involved.

With regard to the possible actions in the committee’s paper, the Scottish Government could try to extrapolate Scottish figures from the survey, although I do not think that the experience here will be particularly different from that in the rest of the UK. I know that the petitioner would like the committee to take evidence, if possible, from Dr John Midgley, who has a lot of good knowledge and experience to share and is willing to speak to the committee. The previous committee was thinking about that, and it is something that I would recommend.

For me, it would be ideal if the committee did its own inquiry or mini inquiry into the issue, although I do not know what the committee’s workload or timescales are. However, the committee has taken a huge interest in the petition for such a long time and I think that the petitioner would think that an inquiry is worth doing. The thyroid issue also takes in other issues, such as fibromyalgia and myalgic encephalopathy. For example, figures show that quite a high proportion of people with ME have an underactive thyroid. So, the thyroid condition could be having an undiagnosed impact on other conditions.

I make a plea to the committee to build on the work that has been done over the past five years and see whether it can come to any conclusions or produce any outcomes.

Angus MacDonald SNP Falkirk East
link

Clearly, the Public Petitions Committee has been looking at the petition for some time. I have said on the record in previous evidence sessions that I am unable to comprehend why desiccated thyroid hormone is not more freely available. It is beyond me why that is not the case, particularly when we hear of patients having to buy desiccated thyroid hormone from abroad on the internet—that is beyond belief. This is such an important issue and I would definitely be loth to close the petition. There is merit in Elaine Smith’s suggestion of a mini inquiry. Perhaps we can keep the petition open until we have a look at our work programme and then bring it back to the committee at the first available opportunity afterwards.

Johann Lamont Lab The Convener · Glasgow
link

That seems sensible. In the meantime, it would probably be worth flagging up to the Scottish Government that we are interested in what it proposes to do around the petition and particularly whether it can take the Scottish figures out of Thyroid UK’s survey. However, we can certainly look at the feasibility of having an evidence-taking session on the petition or something more substantial than that.

Rona Mackay SNP Strathkelvin and Bearsden
link

It would be useful to have Dr Midgley here for an evidence session to give us some medical guidance.

Johann Lamont Lab The Convener · Glasgow
link

Okay. Is It worth contacting him to ask whether he has written evidence that he could share with the committee?

Elaine Smith Lab Central Scotland
link

Convener, the committee already has a lot of written evidence. The round table way back at the beginning was a bit establishment focused, whereas part of the issue is about not doing things in the way that they have always been done—it is about looking at things a bit differently and looking at other evidence that is out there. The medical establishment—big pharma—has the only products that can be used, such as T4. It is also worrying that there is only one manufacturer of T3 in the whole UK. I make a plea for us to get different evidence.

Johann Lamont Lab The Convener · Glasgow
link

We will look at the issue when we consider our work programme, but we will certainly write to the Scottish Government in the meantime.

  1. 09:30 New Petitions Petitions · 50
  2. 10:00 New Petitions Petitions · 20
  3. 10:15 New Petitions Petitions · 7
  4. 10:15 New Petitions Petitions · 3
  5. 10:15 Continued Petitions Petitions · 1
  6. 10:30 Continued Petitions Petitions · 20
  7. 10:30 Continued Petitions Petitions · 13
  8. 10:30 Continued Petitions Petitions · 8
  9. 10:30 Continued Petitions Petitions · 4
  10. 10:30 Continued Petitions Petitions · 6
  11. 10:30 Continued Petitions Petitions · 4
  12. 10:30 Continued Petitions Petitions · 5
  13. 10:30 Continued Petitions Petitions · 7
  14. 11:00 Continued Petitions Petitions · 14
  15. 11:00 Continued Petitions Petitions · 4

The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.